Home>News & Events>Publications>C-Path

News & Events

  • May 10, 2010

    Kidney injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies

    Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV. Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies. Nature Biotechnology. 2010 May;28(5):478–85.

     

  • May 10, 2010

    Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development

    Sistare FD, Dieterle F, Troth S, Holder DJ, Gerhold D, Andrews-Cleavenger D, Baer W, Betton G, Bounous D, Carl K, Collins N, Goering P, Goodsaid F, Gu YZ, Guilpin V, Harpur E, Hassan A, Jacobson-Kram D, Kasper P, Laurie D, Lima BS, Maciulaitis R, Mattes W, Maurer G, Obert LA, Ozer J, Papaluca-Amati M, Phillips JA, Pinches M, Schipper MJ, Thompson KL, Vamvakas S, Vidal JM, Vonderscher J, Walker E, Webb C, Yu Y. Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development. Nature Biotechnology. 2010 May;28(5):446–54.

1 … 28 29 30
Refine:

Period

Program

  • All Programs
  • CPAD - Critical Path For Alzheimer's Disease
  • TTC - Transplant Therapeutics Consortium
  • T1D - Type 1 Diabetes Consortium
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • QuantMed - Quantitative Medicine Program
  • PredicTox KE - PredicTox Knowledge Environment
  • CDRC - CURE Drug Repurposing Collaboratory
  • SHIP-MD - System of Hospitals for Innovation in Pediatrics – Medical Devices
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • CP-SCD - Critical Path for Sickle Cell Disease
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • TRxA - Translational Therapeutics Accelerator
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • CPA-1 - Critical Path for Alpha-1 Antitrypsin Deficiency
  • CFAST - Coalition For Accelerating Standards and Therapies
  • BmDR - Biomarker Data Repository
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x